黃怡超教授(Yi-Tsau Huang, Professor)論文發表

Publications

A. 英文原著論文

  1. Huang, Y.-T., Hamilton, C.A., and Reid, J.L. 1989. Endothelin stimulates phosphatidylinositol hydrolysis in rat vascular smooth muscle. J. Hypertens. 7: 703-705. (sci)

  2. Hamilton, C.A., Huang, Y.-T., and Reid, J.L. 1992.  Effects of endothelin upon blood pressure in normotensive rabbits and in perinephritis hypertension. J. Hypertens. 10: 787-794. (sci)

  3. Hamilton, C.A., Boyle, J.J., Huang, Y.T., McCulloch, J., Nixon, G.F., and Pryadarshi, S. 1994. Agonist desensitisation of 1-adrenoceptors and endothelin-1 receptors coupled to phosphatidylinositol metabolism. Fundam. Clin. Pharmacol. 8: 162-172. (sci)

  4. Huang, Y.-T., Lo, J.-W., Lin, H.-C., Tsai, Y.-T., Hong, C.-Y., and Yang, M.C.M. 1995. Change in vascular cAMP and cGMP contents in portal hypertensive rats. Pharmacology 50: 86-91. (sci)

  5. Huang, Y.-T., Yu, P.-C., Lee, M.-.F., Lin, H.-C., Hong, C.-Y., and Yang, M.C.M. 1995. Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats. Can. J. Physiol. Pharmacol. 73: 378-382. (sci)

  6. Huang, Y.-T., Wang, G.-F., Chen, C.-F., Chen, C.-C., Hong, C.-Y., and Yang, M.C.M. 1995. Fructus Aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 57: 2011-2020. (sci)

  7. Hong, C.Y., Lai, L.J., and Huang, Y.T. 1995. Endothelium-dependent vasorelaxant effect of trilinolein: mediated by nitric oxide and cGMP. Life Sci. 57: 1309-1315. (sci)

  8. Huang, Y.-T., Lin, H.-C., Yu, P.-C., Lee, F.-.Y., Tsai, Y.-T., Lee, S.-D., and Yang, M.C.M. 1996. Decreased vascular reactivity of portal vein in rats with portal hypertension. J. Hepatol. 24: 194-199. (sci)

  9. Huang, Y.-T., Wang, G.-F., Yang, M.C.M., Chang, S.-P., Lin, H.-C., and Hong, C.-Y.  1996. Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.  J. Pharmacol. Exp. Ther. 278: 535-541. (sci)

  10. Huang, Y.-T., Tsai, J.-F., Liu, T.-B., Hong, C.-Y., Yang, M.C.M., and Lin, H.-C. 1996. Chronic administration of octreotide improves vascular responsiveness in portal hypertensive rats. Clin. Sci. 91:601-606(sci)

  11. Lin, H.-C., Yang, M.C.M., Ho, M.-C., Lee, F.-Y., Huang, Y.-T., Lin, L.-F., Li, S.-M., Hwang, S.-S., Wang, S.-S., Tsai, Y.-T., and Lee, S.-D. 1996. Hyperglucagonemia in cirrhotic patients and its relationship to the severity of cirrhosis and hemodynamic values. J. Gastroenterol. Hepatol. 11: 422-428. (sci)

  12. Lin, H.-C., Yang, M.C.M., Ho, M.-C., Li, S.-M., Huang, Y.-T., Yu, P.-C., Tsai, Y.-T., and Lee, S.-D. 1996. Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology 23: 537-543. (sci)

  13. Huang, Y.-T., Chang, S.-P., Lin, H.-C., Yang, M.C.M., and Hong, C.-Y. 1997. Inositol phosphate responses in portal veins from portal hypertensive rats: receptor- and nonreceptor-mediated responses. J. Hepatol. 26: 376-381. (sci)

  14. Liu, T.-B., Lin, H.-C., Huang, Y.-T.*, Sun, C.-M., and Hong, C.-Y. 1997. Portal hypotensive effects of tetrandrine and verapamil on portal hypertensive rats. J. Pharm. Pharmacol. 49: 85-88. (sci)   (*Corresponding author)

  15. Lin, H.-C., Yang, M.C.M., Huang, Y.-T., Yu, P.-C., Ho, M.-C., Hong, C.-Y. and Lee, S.-D. 1997. The hemodynamic effects of AT-112, an analog of ketanserin, in portal vein-stenosed rats. Pharmacology 54: 16-23. (sci)

  16. Huang, Y.-T., Lin, H.-C., Tsai, J.-F., Hou, M.-C., and Hong, C.-Y. 1997. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats. Eur. J. Clin. Invest. 27: 550-555. (SCI)

  17. Huang, Y.-T., Liu, T.-B., Lin, H.-C., Yang, M.C.M., and Hong, C.-Y. 1997. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats. Pharmacology 54: 225-231. (sci)

  18. Huang, Y.-T., Cheng, Y.-R., Lin, H.-C., Chen, C.-F., and Hong, C.-Y. 1997. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats. J. Gastroenterol. Hepatol. 12: 585-589(sci)

  19. Huang, Y.-T., Liu, T.-B., Cheng, Y.-R., Lin, H.-C., Chen, C.-F., and Chen, S.-M. 1997. Chronic portal hypotensive effects of tetrandrine and verapamil on portal hypertensive rats. Asia Pac. J. Pharmacol. 12: 31-35(sci)

  20. Huang, Y.-T., Cheng, Y.-R., Lin, H.-C., Chen, C.-F., and Hong, C.-Y. 1997. Haemodynamic effects of chronic tetrandrine treatment in Sprague-Dawley rats. Chin. J. Physiol. 40: 175-178.

  21. Huang, Y.-T., Tsai, J.-F., Lin, H.-C., Chen, C.-F., and Hong, C.-Y. 1997. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats. Can. J. Physiol. Pharmacol. 40:1220-1225. (sci)

  22. Huang, Y.-T., Cheng, Y.-R., Lin, H.-C., Hou, M.-C., Lee, S.-D., and and Hong, C.-Y. 1998. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats. Dig. Dis. Sci. 43:358-364. (sci)

  23. Huang, Y.-T., Cheng, Y.-R., Lin, H.-C., Chen, S.-M., and Hong, C.-Y. 1998. Haemodynamic effects of chronic octreotide and tetrandrine treatment in portal hypertensive rats. J. Gastroenterol. Hepatol. 13:266-272(sci)

  24. Huang, Y.-T., Lin, H.-C., Tsai, J.-F., Hou, M.-C., Lee, S.-D., and Hong, C.-Y. 1998. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats. J. Hepatol. 28: 1037-1044. (sci)

  25. Lin, H.-C., Huang, Y.-T., Cheng, Y.-R., Hou, M.-C., Lee, F.Y., Chang, F.-Y., Tsai, Y.-T., and Lee, S.-D. 1998. Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis. Clin. Sci. 94: 645-650. (sci)

  26. Huang, Y.-T., Lin, L.-C., Chern, J.-W., Lin, H.-C., and Hong, C.-Y. 1998. Portal hypotensive effects of DL-028 and prazosin on portal hypertensive rats. Pharmacology 57: 132-138. (sci)

  27. Chang, F.-C., Chen, K.-J., Lin, J.-G., Hong, C.-Y., and Huang, Y.-T. 1998. Portal hypotensive effects of tetramethylpyrazine on portal hypertensive rats. J. Pharm. Pharmacol. 50: 881-884. (sci) (Corresponding author)

  28. Lin, H.-C., Wu, H.-L., Huang, Y.-T.*, Hou, M.-C., and Hong, C.-Y. 1998. Haemodynamic effects of eight-day octreotide and prazosin administration in portal hypertensive rats. Eur. J. Clin. Invest. 28: 622-628. (sci) (*Corresponding author)

  29. Huang, Y.-T., Wu, H.-L., Chern, J.-W., Lin, L.-C., and Hong, C.-Y. 1998. Hemodynamic effects of eight-day DL-028 and octreotide administration in portal hypertensive rats. Scand. J. Gastroenterol. 33: 1303-1309. (sci)

  30. Huang, Y.-T., Chang, F.-C., Chen, K.-J., and Hong, C.-Y. 1999. Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats. Planta Med. 65: 130-134.. (sci)

  31. Huang, Y.-T., Lin, L.-C., Chern, J.-W., Lin, H.-C., and Hong, C.-Y. 1999. Portal hypotensive effects of combined terlipressin and DL-028 on anesthetized portal hypertensive rats. Liver 19: 129-134. (sci)

  32. Chang, F.-C., Huang, Y.-T.*, Hong, C.-Y., Lin, J.-G., and Chen, K.-J. 1999. Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats. Eur. J. Gastroenterol. Hepatol. 11: 1027-1031. (sci) (*Corresponding author)

  33. Lin, H.-C., Huang, Y.-T., Wu, H.-L., Lee, W.-C., Hou, M.-C., Lee, F.-Y., Chang, F.-Y., and Lee, S.-D. 1999. Hemodynamic evaluation of prolonged-release lanreotide in rats with portal vein stenosis. J. Hepatol. 31: 482-488. (sci)

  34. Chang, F.-C., Huang, Y.-T.*, Lin, H.-C., Hong, C.-Y., Lin, J.-G., and Chen, K.-J. 1999. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats. Can. J. Physiol. Pharmacol. 77: 618-624. (sci) (*Corresponding author)

  35. Huang, Y.-T., Lin, H.-C., Chang, Y.-Y., Yang, Y.-Y., Chang, F.-Y., and Lee, S.-D. 2001. Hemodynamic effects of synephrine in portal hypertensive rats. Jpn. J. Pharmacol. 85: 183-188. (sci)

  36. Huang, Y.-T., Lee, T.-Y., Lin, H.-C., Chou, T.-Y., Yang, Y.-Y., and Hong, C.-Y. 2001. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats. Can. J. Physiol. Pharmacol. 79: 566-572. (sci)

  37. Yang, Y.-Y., Lin, H.-C., Huang, Y.-T., Lee, T.-Y., Lee, W.-C., Hou, M.-C., Lee, F.-Y., Chang, F.-Y., and Lee, S.-D.2001. Adaptive vasodilatory response after octreotide treatment. Am. J. Physiol. 281: G117-G123. (sci) 

  38. Yang, Y.-Y., Lin, H.-C., Huang, Y.-T., Lee, T.-Y., Hou, M.-C., Lee, F.-Y., Liu, R.-S., Chang, F.-Y., and Lee, S.-D. 2002. Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension. J. Hepatol. 36: 600-606. (sci) 

  39. Huang, Y.-T., Hsu, Y.-C., Chen, C.-J., Liu, C.-T., and Wei., Y.-H. 2003.Oxidative stress related changes in the liver of bile duct ligated rats. J. Biomed. Sci. 10: 170-178. (sci)

  40. Hsu Y-T, Chiu Y-T, Lee C-Y, Lin Y-L, Huang, Y.-T.* 2004. Increases in fibrosis-related gene transcripts in dimethylnitrosamine-intoxicated rat livers J. Biomed. Sci. 11:408-417. (sci) (*Correponding author)

  41. Hsu Y-T, Lin Y-L, Chiu Y-T, Shiao M-S, Lee C-Y, Huang, Y.-T.*  2005. Anti-fibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. J. Biomed. Sci. 12:185-195. (sci) (*Correponding author)

  42. Lin Y-L, Lee T-F, Huang Y-J, . Huang, Y.-T.* 2005. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cell. J. Gastroenterol. Hepatol., 21:1257-1265. (sci) (*Correponding author)

  43. Lin Y-L, Wu C-H, Luo M-H, Huang Y-J, Wang C-N, Shiao M-S, Huang Y-T*. 2006. In vitro protective efects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J. Ethnopharmacol, 105:215-222. (sci) (*Correponding author)

  44. Chong L-W, Hsu Y-C, Chiu Y-T, Yang K-C, Huang, Y.-T.* 2006. Antifibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J. Biomed. Sci, 13: 403-418. (sci) (*Correponding author)

  45. Lin Y-L, Lee T-F, Huang Y-J, Huang, Y-T.* 2006. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. J. Pharm. Pharmacol. 58: 933-939. (SCI) (*Correponding author)

  46. Hsu Y-C, Chiu Y-T, Lee C-Y, Wu C-F, Huang, Y.-T.* 2006. Antifibrotic effects of tetrandrine on bile duct ligated rats. Can. J. Physiol. Pharmacol. 84: 967-976. (SCI) (*Correponding author)

  47. Hsu Y-C, Chiu Y-T, Cheng C-C, Wu C-F, Lin Y-L, Huang Y.-T.* 2007. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J. Gastroenterol. Hepatol. 22:99-111. (SCI) (*Correponding author)

  48. Lee T-F, Lin Y-L, Huang Y.-T.* 2007. Anti-proliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. Planta Med. 73:527-534. (SCI) (*Correponding author)

  49. Lin Y-L, Hsu Y-C, Chiu Y-T, Huang Y.-T.* 2008. Anti-fibrotic effects of a herbal combination regimen on hepatic fibrotic rats. Phytother. Res. 22: 69-76. (SCI) (*Correponding author)

  50. Chang L-C, Huang N, Chou Y-J, Kao F-Y, Hsieh P-C, Huang Y.-T.* 2008. Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: a population-based study. J. Clin. Pharm. Ther. 33:243-249. (SCI) (*Correponding author)

  51. Chang L-C, Huang N, Kao F-Y, Lee C-H, Chou Y-J, Huang Y.-T.* 2008. Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003. BMC Health Serv. Res.,8: 170. (SCI) (*Correponding author)

  52. Lin Y-L, Wu C-F, Huang Y.-T.* 2008. Effects of Rhubarb on migration of rat hepatic stellate cells. J. Gastroenterol. Hepatol. 24: 453-461. (SCI) (*Correponding author)

  53. Lin Y-L, Lin C-Y, Chi C-W, Huang Y.-T.* 2008. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother. Res., 23: 927-932.(SCI). (*Correponding author)

  54. Weng T-C, Shen C-C, Chiu Y-T, Kuo, C-D, Lin Y-L, Huang Y.-T.* 2009. Inhibitory effects of armepavine against hepatic fibrosis in rats. J. Biomed. Sci, 13: 403-418. (SCI) (*Correponding author)

  55. Tsai M-K, Lin Y-L, Huang Y.-T.* 2009. Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Toxicol. Appl. Pharmacol., in press. (SCI) (*Correponding author)

B. 英文評述論文

  1. Huang, Y.-T., and Hong, C.-Y. 1997. Current studies of traditional Chinese medicine: a review. J. Food Drug Anal. 5: 265-272. (sci)

  2. Huang, Y.-T., and Hong, C.-Y. 1998. Alternative medicine-Formulary evaluation in Asia. Med. Prog. 25 (June): 5-7. 

  3. Huang, Y.-T., and Hong, C.-Y. 1998. Tetrandrine. Cardiovasc. Drug Rev. 16: 1-15. (sci)

  4. Bomzon, A., and Huang, Y.-T. 2001. Vascular smooth muscle cell signaling in cirrhosis and portal hypertension. Pharmacol. Ther. 89:255-272. (sci)

C. Articles in Chinese 

  1. 黃怡超、洪傳岳:小柴胡湯預防肝癌之臨床試驗. 當代醫學. 1996;23:1018-1020.

  2. 黃怡超、洪傳岳粉防己鹼的藥理研究. 當代醫學. 1997;24:50-52.

  3. 黃怡超、洪傳岳使用中草藥導致不良效應香港的經驗. 當代醫學. 1997;24:247-248.

  4. 黃怡超、洪傳岳治療糖尿病之草藥. 當代醫學. 1997;24:413-415.

  5. 黃怡超、洪傳岳銀杏. 當代醫學. 1997;24:597-599.

  6. 黃怡超、洪傳岳:抗B型肝炎病毒之草藥印度大戟. 當代醫學. 1997;24,779-781.

  7. 黃怡超、洪傳岳:台灣中醫業現況. 當代醫學. 1997;24,925-927.

  8. 黃怡超、洪傳岳:以中藥治療小兒氣喘之臨床試驗. 當代醫學. 1998;25,80-82.

  9. 黃怡超、洪傳岳:從中草藥提取心臟血管藥物之最新進展. 當代醫學. 1998;25,166-170.

  10. 黃怡超、洪傳岳:貫葉連翹治療憂鬱症與西伯利亞艾菊預防偏頭痛之臨床試驗. 當代醫學. 1998;25,249-252.

  11. 黃怡超:近年有關中草藥之臨床研究論文評介. 中兒醫誌.1998;39增刊A,27-29.

  12. 黃怡超、洪傳岳:草藥所含雌性激素的研究. 當代醫學.1999;26,246-248.

  13. 黃怡超、洪傳岳:台灣婦女服用減肥藥所致肺小支氣管阻塞性病變. 當代醫學.1999;26,350-352.

  14. 黃怡超、洪傳岳:中藥治療腸道過激症候群的臨床試驗. 當代醫學.1999,26,433-435.

  15. 陳永祥、黃怡超:中藥減肥劑造成腎尿路癌病變. 當代醫學.2001,28,406-410.

  16. 黃怡超:從銀杏談中草藥產業開發. 生物醫學報導 第七期. 2001,13-15.

  17. 許益超、黃怡超:補充療法及替代醫學領域發展之新契機. 當代醫學2004; 31, 237-242.

  18. 張麗晴、黃怡超:整合醫學:合作抑是箝制? 當代醫學2005; 32, 418-421.

  19. 黃怡超:傳統療法的前景與挑戰. 科學發展第401. 20065, 6-9.

  20. 翁鼎鈞、黃怡超:全反式維甲酸併用三氧化二砷對新近診斷急性前髓型白血病 的療效研究.當代醫學2006; 33, 399-403.

  21. 郭忠楨、黃怡超:中藥複方對增加老年人活力、記憶力、性功能及生活品質 隨機對照臨床試驗.當代醫學2006; 33, 634-637.

  22. 蔡明桂、黃怡超:小蘗鹼降低血中膽固醇的藥理作用.當代醫學2006; 33, 977-980.

  23. 黃怡超:銀杏預防老年痴呆的隨機對照臨床試驗.當代醫學2009; 36, 144-146.

  24. 蘇彥伯、黃怡超:草藥複方STW 5對功能性消化不良的療效評估 – 一個多中心、隨機、雙盲對照的臨床試驗.當代醫學2009; 36, 307-311.

  25. 吳青芬、黃怡超:水飛薊萃取物標準品抑制T細胞發炎細胞素、肝細胞NF-kB訊息傳遞以及C型肝炎病毒感染.當代醫學2009; 36, 553-557.

回首頁